Physician profile
Simil S Gala
NPI 1073716445
$4,353.55
in general payments reported to CMS, 2019-2025
20 companies · $809 in 2025
The $809 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $881 · 2020: $82.57 · 2021: $312 · 2022: $524 · 2023: $807 · 2024: $938 · 2025: $809.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,553.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,026.65 | 2019-2025 | |
| Edwards Lifesciences Corporation | $332.09 | 2019-2023 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $314.01 | 2022-2025 | Symplicity G3, Onyx Frontier |
| Astrazeneca Pharmaceuticals Lp | $284.54 | 2019-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $277.17 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $233.71 | 2019-2021 | |
| Medtronic Vascular, INC. | $143.77 | 2019 | |
| Gilead Sciences, INC. | $125.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $99.42 | 2021-2023 | Xarelto |
| Biotronik INC. | $93.43 | 2019-2025 | |
| Pfizer INC. | $92.62 | 2024 | |
| Shockwave Medical, INC | $78.48 | 2025 | |
| Boston Scientific Corporation | $70.26 | 2022 | |
| Bridgebio Pharma, INC. | $50.81 | 2025 | Attruby |
| Lexicon Pharmaceuticals, INC. | $44.95 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $25.95 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.74 | 2025 | Lifevest |
| Abiomed | $15.19 | 2023 | Impella |
| Silk Road Medical, INC. | $12.99 | 2022 | |
| Cardiovascular Systems INC. | $12.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simil Gala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.